The abstract is read at the publisher; the summary is JClub's.
SIRT2 acts as a zonated cholesterol sensor in zone 1 hepatocytes, and its activity is linked to MASLD-associated hepatocellular carcinoma with 27-hydroxycholesterol accumulation.
- Why it matters: MASLD is a major driver of HCC, yet how liver metabolic zonation shapes regional tumor transformation is not well defined.
- What they did: Using lineage tracing and mouse and human hepatic organoid models, the study tested SIRT2 gain or loss, showing cholesterol binding activates SIRT2 to deacetylate SCP2 at Lys546 and alter CYP7B1-linked bile acid programs.
- The result: SIRT2 overexpression in zone 1 promotes HCC, while deletion or inhibition prevents carcinogenesis by restoring cholesterol/bile acid metabolism and CD8+ T cell recruitment, and patient tissue shows zonal SIRT2 and CYP7B1 dysregulation.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.